Introduction
this method provided an alternative to venous INR testing, it was cumbersome, time consuming and the potential for operator-error was great. The advent of POC coagulation analysers offered a potential alternative to the Thrombotest.
This study sought to determine the reliability and accuracy of INR determination by two capillary whole-blood methods (Thrombotest and CoaguChek) compared to the reference method of venous collection with laboratory analysis, in a pediatric population. For the purpose of this study, the venous method of INR determination was deemed to be the "gold standard" (23) .
Methods Patients
Patients receiving warfarin were identified through the Departments of Hematology and Cardiology at RCH. All patients presenting to the Pathology Collection Department for an INR test were eligible for this study, and informed consent was sought. The RCH Ethics in Human Research committee approved this project.
Blood sample collection
Upon providing written informed consent, three procedures for INR determination were performed: a Thrombotest INR, a CoaguChek INR and a venous blood INR.
Blood was obtained from a single finger prick for the Thrombotest and CoaguChek INRs, using an Autolet lancet (Ulster Scientific, Inc., Highland, NY). Staff who performed the Thrombotest were blinded from the result of the CoaguChek. Local anaesthetic cream was applied to the ante-cubital fossa thirty minutes prior to venipuncture, to reduce associated pain. Venous blood was drawn directly into a 3.2% citrate tube (SMonovette, Sarstedt, Germany). Venous samples were delivered to the RCH Core Laboratory within 30 minutes of collection.
Blood sample analysis
Thrombotest 250 µl of the Thrombotest reagent ISI ≈ 1.00 (Nycomed Pharma AS, Oslo, Norway) was transferred into a small clotting tube, and placed in a water-bath at 37°C, for approximately 3 minutes. 50 µl of the capillary blood sample was added from the pipette just above the surface of the reagent. Mixing of blood and reagents initiated the clotting reaction. The time required for clot formation was recorded, and a conversion chart was used to express the result as an INR.
All clinical decisions during the study were based on the Thrombotest INR result, which was the current standard of care.
CoaguChek
This method has previously been reported (9) . The first drop of whole blood obtained, following lancing of the finger, was placed onto the test area. The monitor determined the PT, and displayed the result as an INR within one minute of beginning the analysis.
Venous
Platelet Poor Plasma (PPP) was obtained following centrifugation (3000g for 10min) of the venous blood sample. Analysis of the sample was performed on the ACL 100 coagulation analyser (Instrumentation Laboratory srl -Milan, Italy). The ISI of the thromboplastin reagent (IL Test PT-Fibrinogen, Instrumentation Laboratory-Milan, Italy) was 1.26. The mean normal PT was determined from a local population of not less than 25 individuals. The Haematology laboratory at RCH complies with the Quality Assurance Program established by the Royal College of Pathologists of Australasia (RCPA).
Statistical analysis
Values are expressed as mean and 95% confidence intervals (CI). Lin's concordance correlation coefficient (r) was calculated as a measure of agreement between the CoaguChek, Thrombotest and venous INR (10). Bland-Altman analysis of limits-of-agreement was used to show the average difference between the methods compared, together with the variability of the differences and the overall trend (11) . Statistical software package STATA, Release 7.0 (Stata Corporation, College station, TX) was used for data processing and analysis.
Results
18 children (10 females and 8 males) participated in the study, with an age range of 9 months to 21 years (mean 11.9 years; SD 5.03 years). A total of forty test points were performed over 6 months.
Indications for warfarin therapy included congenital heart disease (66%), cardiac arrhythmia (11%), prosthetic heart valve replacement (11%), cardiomyopathy (6%) and deep vein thrombosis (6%). There were no significant thrombotic or hemorrhagic complications during the study period.
Mean INR values for each method are summarised in Table 1 . Figures 1A and 1B show the concordance curves for the comparison of Thrombotest and CoaguChek (respectively) 
Discussion
Frequent blood monitoring of children requiring long-term warfarin therapy can be traumatic, particularly when venous access is difficult. Capillary whole blood monitoring of oral anticoagulant therapy offers tremendous advantages in the management of children. Overcoming the need for frequent venipuncture reduces parental and patient anxiety, with the potential to improve compliance with management plans.
We compared two capillary whole blood methods of INR measurement (Thrombotest and CoaguChek) with venous INR results. Capillary whole blood monitoring using a modified Thrombotest method had been the standard practice for INR measurement at RCH for nearly two decades. Technological advances have lead to the development of user-friendly POC analysers that provide good accuracy using smaller blood samples (12) . Numerous studies have shown CoaguChek to be a reliable instrument for INR determination in adult patients requiring anticoagulant therapy (13) (14) (15) (16) (17) (18) (19) . In comparison, there has only been one study evaluating the clinical effectiveness of CoaguChek compared to venous INR monitoring in children (9) . This study is significant as it provides objective evidence as to the accuracy and validity of INR results obtained by POC monitoring using the CoaguChek monitor in a pediatric population. Similar studies in adults cannot simply be extrapolated to the pediatric population, and only one similar pediatric study has previously been published. The impact of developmental hemostasis, underlying disease pathology and variable agerelated dose response to warfarin all make managing warfarin in children different to adult management (2, 4, 9) . For this reason, investigation into strategies that optimise warfarin management in children are essential, despite the fact that similar studies have already been conducted in the adult population.
CoaguChek was found to be more precise and accurate than Thrombotest, when compared to our gold standard method of venous INR. Sub-analysis of results obtained from patients with a target INR of 2.5 demonstrated that CoaguChek results crossed into or out of the therapeutic range (2.0-3.0) compared to the venous INR, on 25% of samples. This compares favourably to the previously published study of CoaguChek's use in children, where 29% of CoaguChek INR results crossed into or out of the therapeutic range compared to venous results (9) . Of important clinical significance, this study demonstrated that using Thrombotest INR results, treatment decisions would have differed from that indicated by the venous INR on eleven occasions, compared to only one difference based upon CoaguChek results.
Gosselin et al., reported a correlation coefficient of 0.900 between the CoaguChek Plus and a laboratory-based method (20) . The correlation in our study was slightly reduced compared to Gosselin. This may reflect the inherent challenges of collecting any blood sample, even capillary samples, from children. It may also reflect local laboratory differences associated with calibration of the international sensitivity indices of thromboplastins. However, our correlation is significantly better com- pared to that reported by Kemme et al. (21) , who examined POC monitoring of anticoagulant therapy in patients commencing warfarin, whilst our study only enrolled patients in the maintenance phase of warfarin therapy. The strength of this study's findings is limited by our relatively small sample size. Recruitment of children into this study was difficult as it necessitated the collection of venous blood, a procedure our patients do not usually have to endure. The staff of the RCH Pathology Collection Department performed all of the capillary punctures required during this study. They were all experienced in the collection of blood samples from infants and children, and had no difficulty in obtaining blood droplets of sufficient size to facilitate CoaguChek INR determination. Health professionals less experienced in capillary collection in infants and children may not be as successful in the use of the CoaguChek. This study only investigated the use of the CoaguChek POC monitor within a tertiary pediatric centre. One study has evaluated the CoaguChek monitor in the context of a home-monitoring program. Whilst correlation between the home INR and reference laboratory INR was acceptable (r 2 = 0.87; y 2 =1.1x -0.2), it was not as high as the correlation between the laboratory INR and CoaguChek INR performed by clinic staff. The accuracy of POC testing using the CoaguChek in the context of home-monitoring is yet to be validated.
This study demonstrates that INR monitoring using the CoaguChek POC device is more accurate and reliable compared to our standard method of INR testing, the Thrombotest. Statistical analysis demonstrated that the CoaguChek monitor achieved a high level of correlation when compared to our reference method of venous INR testing. The findings of this study offer such strong support for CoaguChek's use in INR monitoring in children that it has become the standard method of INR testing at RCH. Further study is required to determine whether the relative accuracy of CoaguChek can be maintained during home use. Anticoagulant management in infants and children presents unique challenges that do not exist in the adult population. The availability of POC monitoring options that have been validated in the pediatric population will significantly improve one aspect of this management.
